由于糖尿病病例的增长,到2027年全球护理诊断市场将达到350亿美元
ByLabmedica Internationalstaff writers
2021年11月25日
The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic cases, technological developments in point of care devices and increased investments by the key players.
此外,慢性病和传染病的患病率上升,例如心脏病,肝炎,癌症,胃肠道,呼吸道和性传播疾病(STD),正在推动护理诊断点市场。这些是估值报告的最新发现(印度班加罗尔),这是市场研究报告和行业分析的提供商。
An increase in the number of diabetic cases is expected to drive the growth of the point of care diagnostics market. The adoption of blood glucose monitoring systems is increasing due to factors such as the growing number of diabetic patients, increased patient knowledge of the importance of blood sugar monitoring, and the development of novel monitoring devices by important players. Other key factors likely to drive the growth of the point of care diagnostics market include the rising prevalence of other respiratory illnesses around the world, the shift toward decentralized diagnostics, and improved access to point-of-care devices through online platforms.
Point of care testing can significantly enhance the management of infectious diseases, particularly in underdeveloped nations where prompt medical care is difficult to come by and healthcare infrastructure is lacking. Furthermore, government incentives and grants for the development of new products are accelerating the adoption of improved diagnostic technology for infectious diseases. People in undeveloped and developing countries can now afford these tests thanks to such initiatives. During the forecast period, factors such as the increasing number of clinics implementing point of care testing for the rapid identification of infectious diseases are expected to fuel market growth.
快速诊断中的纳米技术集成也有望推动护理诊断市场的增长。通过技术改进,至关重要的是,要实施高质量的医疗保健管理以快速患者护理。纳米技术使科学家可以研究广泛的医疗保健应用。通过基于纳米技术的护理诊断点的生产,将进一步提高产品需求。预计Covid-19爆发将进一步推动护理诊断市场的增长,因为越来越多的护理测试使用点可以快速诊断Covid-19。
根据类型,葡萄糖监测部门预计将是护理诊断市场中最有利可图的。在学术界和学术界,糖尿病患者人群的上升以及对家庭葡萄糖测试的偏爱越来越多的各个方面都促成了这一细分市场规模的所有方面。
Geographically, North America is expected to be the most lucrative region in the global point of care diagnostics market. With the rising incidence and prevalence of lifestyle diseases, the North American market is gaining traction. Furthermore, the presence of key players in the region, favorable government scenario, increased awareness of self-testing and home care products, and significant adoption of novel technologies are all expected to contribute significantly to the growth of the North American point of care diagnostics market.
Related Links:
评估报告
E-mail
Print